Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FKMQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,863
Award facts
- Contract value 100% obligated
- $1,862.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,862.70 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringe format, with a completion date of July 24, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement executed on July 23, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience fulfilling DLA Medical Supply Chain requirements. The company's federal contract portfolio demonstrates consistent capability to deliver brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This Boostrix TDAP vaccine delivery order supports the Defense Health Agency and broader military healthcare systems' immunization requirements and reflects the contractor's proven ability to meet federal procurement standards through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FKMQW?
SPE2DB25FKMQW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FKMQW worth?
The government has obligated $1,863 on SPE2DB25FKMQW.
Is contract SPE2DB25FKMQW an order under another contract?
Yes. SPE2DB25FKMQW is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMQW competed?
The extent of competition for SPE2DB25FKMQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award